Suchergebnisse - %22SARS-CoV-2%22

PubPharm (1.261)

71

Postinfectious conditions challenge disease-specificity of SNOT-22

enthalten in: European archives of oto-rhino-laryngology and head & neck | 2024

von Hildebrandt, M. | Møller, P. | Fjældstad, A. | +1

72

Synthesis, molecular docking analysis, molecular dynamic simulation, ADMET, DFT, and drug likeness studies : Novel Indeno[1,2-b]pyrrol-4(1H)-one as SARS-CoV-2 main protease inhibitors

enthalten in: PloS one | 2024

von Gheidari, D. | Mehrdad, M. | Bayat, M.

73

The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8

in: mBio | 2024

von Lujie Fan | Yuzheng Zhou | Xiafei Wei | +11

74

Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot–Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection

in: Frontiers in Neurology | 2024

von Da Li | Hu Yu | Min Zhou | +3

75

Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluation

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Dou, X. | Sun, Q. | Liu, Y. | +10

76

Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Herzog, A. | Göbel, K. | Marongiu, L. | +11

77

A naturally occurring G11S mutation in the 3C-like protease from the SARS-CoV-2 virus dramatically weakens the dimer interface

enthalten in: Protein science : a publication of the Protein Society | 2024

von Wang, G. | Venegas, F. | Rueda, A. | +5

78

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2024

von Biernacki, K. | Ciupak, O. | Daśko, M. | +7

79

Applications of peptide-functionalized or unfunctionalized selenium nanoparticles for the passivation of SARS-CoV-2 variants and the respiratory syncytial virus (RSV)

enthalten in: Colloids and surfaces. B, Biointerfaces | 2024

von Nahhas, A. | Webster, T.

80

Applying the bioisosterism strategy to obtain lead compounds against SARS-CoV-2 cysteine proteases : An in-silico approach

enthalten in: Journal of computational chemistry | 2024

von Borba, J. | de Araújo, L. | Veloso, M. | +1